GNGB.F Stock Overview
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Getinge AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr21.17 |
52 Week High | kr23.69 |
52 Week Low | kr16.76 |
Beta | 0.56 |
1 Month Change | 8.23% |
3 Month Change | 11.42% |
1 Year Change | n/a |
3 Year Change | -35.46% |
5 Year Change | 60.38% |
Change since IPO | 85.70% |
Recent News & Updates
Recent updates
Shareholder Returns
GNGB.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 0.04% | 0.7% |
1Y | n/a | -0.9% | 23.9% |
Return vs Industry: Insufficient data to determine how GNGB.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how GNGB.F performed against the US Market.
Price Volatility
GNGB.F volatility | |
---|---|
GNGB.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GNGB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GNGB.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1904 | 11,862 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
GNGB.F fundamental statistics | |
---|---|
Market cap | US$5.85b |
Earnings (TTM) | US$211.27m |
Revenue (TTM) | US$2.98b |
27.7x
P/E Ratio2.0x
P/S RatioIs GNGB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GNGB.F income statement (TTM) | |
---|---|
Revenue | kr32.20b |
Cost of Revenue | kr17.59b |
Gross Profit | kr14.61b |
Other Expenses | kr12.32b |
Earnings | kr2.29b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 18, 2024
Earnings per share (EPS) | 8.39 |
Gross Margin | 45.37% |
Net Profit Margin | 7.10% |
Debt/Equity Ratio | 20.1% |
How did GNGB.F perform over the long term?
See historical performance and comparison